Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth

+19.73%
3Y annualised
+1.23% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 27 Oct '26
₹23.57
Min. for SIP
--
Fund size (AUM)
₹191.85 Cr
Expense ratio
1.10%
Rating
3

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
6 months₹30,000₹30,564
+1.88%
1 year₹60,000₹63,914
+6.52%
3 years₹1,80,000₹2,17,365
+20.76%
5 years₹3,00,000₹4,40,079
+46.69%

Holdings (48)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries LtdHealthcareEquity10.45%
Divi's Laboratories LtdHealthcareEquity7.09%
Eli Lilly Forgn. Eq (LLY)HealthcareForeign - Equity6.46%
Apollo Hospitals Enterprise LtdHealthcareEquity5.25%
Johnson & Johnson Ltd. Forgn. Eq (JNJ)HealthcareForeign - Equity4.45%
Laurus Labs LtdHealthcareEquity4.44%
Torrent Pharmaceuticals LtdHealthcareEquity4.38%
Cipla LtdHealthcareEquity4.34%
Max Healthcare Institute LtdHealthcareEquity4.19%
Dr. Reddy's Laboratories LtdHealthcareEquity3.95%
AbbVie Inc Forgn. Eq (ABBV)HealthcareForeign - Equity3.22%
Lupin LtdHealthcareEquity2.97%
Aurobindo Pharma LtdHealthcareEquity2.77%
Merck & Co Inc (US) Forgn. Eq (MRK)HealthcareForeign - Equity2.50%
Fortis Healthcare LtdHealthcareEquity2.41%
Glenmark Pharmaceuticals LtdHealthcareEquity2.11%
Novartis AG ADS/ADR (NVS)HealthcareADS/ADR1.82%
Thermo Fisher Scientific Inc Forgn. Eq (TMO)HealthcareForeign - Equity1.75%
Ipca Laboratories LtdHealthcareEquity1.72%
Mankind Pharma Ltd.HealthcareEquity1.65%
Amgen Inc. (USA) Forgn. Eq (AMGN)HealthcareForeign - Equity1.59%
Biocon LtdHealthcareEquity1.47%
Alkem Laboratories LtdHealthcareEquity1.38%
Zydus Lifesciences LtdHealthcareEquity1.37%
Gland Pharma LtdHealthcareEquity1.37%
Gilead Sciences Inc. (USA) Forgn. Eq (GILD)HealthcareForeign - Equity1.29%
Abbott Laboratories Forgn. Eq (ABT)HealthcareForeign - Equity1.20%
Aster DM Healthcare LtdHealthcareEquity1.04%
Ajanta Pharma LtdHealthcareEquity1.01%
Intuitive Surgical Inc. (USA) Forgn. Eq (ISRG)HealthcareForeign - Equity1.00%
Danaher Corporation Forgn. Eq (DHR)HealthcareForeign - Equity0.98%
Vertex Pharmaceuticals Inc. (USA) Forgn. Eq (VRTX)HealthcareForeign - Equity0.93%
Novo Nordisk A/S Forgn. Eq (NVO)HealthcareADS/ADR0.85%
Medtronic Forgn. Eq (MDT)HealthcareForeign - Equity0.77%
Narayana Hrudayalaya LtdHealthcareEquity0.70%
Global Health LtdHealthcareEquity0.70%
Glaxosmithkline Pharmaceuticals LtdHealthcareEquity0.67%
Stryker Corp Forgn. Eq (SYK)HealthcareForeign - Equity0.66%
Wockhardt LtdHealthcareEquity0.62%
Anthem Biosciences Ltd.HealthcareEquity0.55%
Regeneron Pharmaceuticals Inc Forgn. Eq (REGN)HealthcareForeign - Equity0.55%
Becton Dickinson And Co Forgn. Eq (BDX)HealthcareForeign - Equity0.34%
Agilent Technologies Inc Forgn. Eq (A)HealthcareForeign - Equity0.34%
Iqvia Holdings Forgn. Eq (IQV)HealthcareForeign - Equity0.31%
Waters Corporation (WAT)HealthcareForeign - Equity0.30%
Others CBLOUnspecifiedCBLO0.10%
CashUnspecifiedCash0.00%
Net PayablesUnspecifiedNet Payables-0.01%
See All

Minimum investments

Min. for 1st investment
₹100
Min. for 2nd investment
₹100
Min. for SIP
--

Returns and rankings

Annualised returns
Absolute returns
Name1Y3Y5YAll
Fund returns+14.2%+19.7%+13.2%+15.1%
Category average (Equity Sectoral)+4.8%+18.7%+13.0%+16.7%
Rank (Equity Sectoral)597--

Exit load, stamp duty and tax

Exit load

Nil

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data

Fund management

AV
Amit Vora
Feb 2021 - Present
View details

BJ
Bhavesh Jain
Oct 2021 - Present
View details

Education
Mr. Jain is a MMS (Finance) from Mumbai University.
Experience
Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Also manages these schemes

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth is a Equity Mutual Fund Scheme launched by Edelweiss Mutual Fund. This scheme was made available to investors on 30 Apr 2008. Amit Vora is the Current Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹1,73,113 Cr and the Latest NAV as of 27 Oct 2026 is ₹23.57. The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100. ;

Investment Objective

The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Fund benchmarkMSCI India Domestic & World Healthcare 45 Index

Fund house

Rank (total assets)#15 in India
Total AUM₹1,73,112.93 Cr
Date of Incorporation30 Apr 2008
Phone+91 22 4093 3400
E-mail--
Launch Date30 Apr 2008
AddressEdelweiss HouseOff C.S.T. Road,Kalina Mumbai 400098
CustodianStandard Chartered Bank
Registrar & Transfer AgentKFin Tech
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,